Amphastar Pharmaceuticals, Inc. Annual Depreciation in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
  • Amphastar Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $6.82M, a 9.02% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Depreciation for 2023 was $25.2M, a 5.84% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Depreciation for 2022 was $23.8M, a 7.29% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Depreciation for 2021 was $22.2M, a 8.32% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $25.2M +$1.39M +5.84% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $23.8M +$1.62M +7.29% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $22.2M +$1.71M +8.32% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $20.5M +$3.42M +20% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $17.1M +$2.54M +17.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $14.5M +$1.58M +12.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $13M +$793K +6.52% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $12.2M +$847K +7.49% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $11.3M -$1.21M -9.69% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $12.5M +$1.36M +12.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $11.2M +$1.51M +15.7% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $9.66M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.